Try our beta test site
370 studies found for:    Open Studies | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease
Conditions: Elevated Lipoprotein(a);   Cardiovascular Disease
Interventions: Drug: ISIS 681257;   Drug: Placebo
2 Recruiting BIONICS - Pharmacokinetics (PK) Trial
Condition: Heart Disease
Intervention: Device: BioNIR Ridaforolimus Eluting Coronary Stent
3 Recruiting Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
Condition: Congenital Heart Disease
Intervention: Drug: sulphur hexafluoride lipid-type A microspheres
4 Recruiting Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Conditions: Ventricular Premature Complexes;   Myocardial Ischemia
Intervention: Drug: ranolazine
5 Recruiting Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Conditions: Transient Ischemic Attack;   Stroke;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Warfarin
6 Recruiting Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Conditions: Atherosclerosis;   Cardiovascular Disease
Interventions: Biological: MEDI6012;   Biological: Placebo
7 Recruiting Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Conditions: Cardiovascular Diseases;   Statin Adverse Reaction
Interventions: Drug: Bempedoic acid 180 mg tablet;   Drug: Matching placebo tablet
8 Recruiting Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Condition: Chronic Aphasia
Interventions: Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
9 Recruiting Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Conditions: Anemia;   Cardiovascular Disease
Interventions: Drug: EPO;   Drug: Feraheme
10 Not yet recruiting Diffuse Optical Monitoring With Inhaled Nitric Oxide
Condition: Stroke
Intervention: Drug: Nitric Oxide
11 Recruiting Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease
Interventions: Drug: bempedoic acid;   Drug: placebo
12 Recruiting Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease;   Statin Adverse Reaction
Interventions: Drug: bempedoic acid;   Other: placebo
13 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
14 Recruiting The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Conditions: Congenital Heart Disease;   Tetrology of Fallot;   RVOT Anomaly;   Pulmonary Regurgitation
Interventions: Device: Harmony Transcatheter Pulmonary Valve;   Device: Harmony Delivery System
15 Recruiting Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Condition: Chronic Ischemic Stroke
Interventions: Biological: SB623 Implant (2.5M);   Biological: SB623 Implant (5.0M);   Procedure: Sham surgery
16 Recruiting Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
Condition: Heart Failure
Interventions: Device: Jarvik 2000 VAS;   Device: HeartMate II
17 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
18 Recruiting Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Condition: Ischemic Attack, Transient
Interventions: Drug: Clopidogrel;   Drug: placebo
19 Recruiting Study With Healthy Japanese and Non-Asian Participants With BMS-986231
Condition: Heart Decompensation, Acute
Interventions: Drug: BMS-986231;   Drug: BMS-986231 Placebo
20 Recruiting Sub-Q Versus IV Furosemide in Acute Heart Failure
Condition: Congestive Heart Failure
Interventions: Drug: Furosemide Injection Solution (SCP-101);   Drug: Furosemide Injection Solution, USP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.